Psma ADC clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses psma ADC is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- PSMA ADC
- 5
Studies by the year they started
5 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 1
Progenics Pharmaceuticals, Inc. (4) · Heinrich Elinzano, MD (1)
Studies
Open first, then newest update. How each study uses psma ADC is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)CompletedPhase 2Heinrich Elinzano, MDNCT01856933Written as PSMA ADC
- A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)CompletedPhase 2Progenics Pharmaceuticals, Inc.NCT01695044Written as PSMA ADC
- An Open-label Extension Study of PSMA ADC 2301 in mCRPCCompletedPhase 2Progenics Pharmaceuticals, Inc.NCT02020135Written as PSMA ADC
- Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate CancerCompletedPhase 1Progenics Pharmaceuticals, Inc.NCT01414296Written as PSMA ADC
- Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate CancerCompletedPhase 1Progenics Pharmaceuticals, Inc.NCT01414283Written as PSMA ADC